Experimental Procedures
Wittig Synthesis Procedures (2-(1,3-dioxolan-2-yl)ethyl)tripropylphosphonium bromide (1d) A 25 mL flame dried two-neck flask equipped with magnetic stir bar and condenser, was charged with 2-(2-bromoethyl)1,3-dioxalane (3.00 g, 16.57 mmol) and sodium iodide (12.4 mg, 0.820 mmol, 0.05 eq) under nitrogen atmosphere. 10 mL of freshly distilled THF followed by tri-n-propyl phosphine (3.31 mL, 16.5 mmol) was added. The contents were stirred at reflux for 24 h. The reaction was cooled to room temperature and solvent was exchanged for CH 2 Cl 2 (10 mL) and the solution was filtered through celite. The mixture was concentrated under reduced pressure and the residues was washed with hexanes (10 ml), then Et2O (10 ml). The residue was cooled overnight at 7 °C to obtain a white solid. The solid was suspended in hexanes (10 ml), filtered and purged under high vacuum to give the title compound as a white solid (5.38 g, 95% yield).
1 H NMR (600 MHz, CDCl 3 ) δ 4.99 (t, J = 3.6 Hz, 1H), 4.04 -3.97 (m, 2H), 3.92 -3.86 (m, 2H), 2.53 -2.43 (m, 8H), 2.03 -1.97 (m, 2H), 1.70 -1.60 (m, 6H), 1.14 (td, J = 7.2, 1.4 Hz, 9H).
13 C NMR (151 MHz, CDCl 3 ) δ 101.84 (d, J = 13.3 Hz), 65.26, 25.64, 21.42 (d, J = 47 .0 Hz), 15.66 (dd, J = 21.9, 10.1 Hz), 13.07 (d, J = 50.2 Hz).
31 P NMR (243 MHz, CDCl 3 ) δ 33.36.
5-Bromo-2-pentanone (26)
In a 200 mL round bottom flask equipped with a magnetic stir bar was combined α-acetyl-γ-butyrolactone (5.1 mL, 47.1 mmol) and CH 2 Cl 2 (50 mL). To the clear solution was added HBr (48 % aqueous, 50 ml, 440 mmol) dropwise and with vigorous stirring. To the biphasic mixture H 2 SO 4 (0.27 mL, 5.1 mmol) was quickly added, the flask was fitted with a condenser and the mixture was heated under reflux for 3 h under a flow of N 2 . Heating was discontinued and H 2 0 (60 mL) was added to the reaction mixture. Upon cooling, the organic phase was collected and the aqueous was extracted with CH 2 Cl 2 (4 x 25 mL). The combined organic phase was washed with H 2 O (3 x 25 mL), dried (MgSO 4 ) and solvent was removed under reduced pressure to afford a clear light brown liquid (12.1 g). The crude product was purified by vacuum distillation to afford 26 as a clear colourless liquid (7.01 g, 42.5 mmol, 90 % yield).
1
H NMR (600 MHz, CDCl 3 ) δ 3.44 (t, 2H, J = 6.4 Hz), 2.64 (t, 2H, J = 7.0 Hz) 2.16 (s, 3H), 2.10 (m, 2H); 13 C NMR (151 MHz, CDCl 3 ) δ 207. 31, 41.41, 33.31, 30.06, 26.36 .
General procedure for ketal synthesis:
To a 10 mL round bottom flask equipped with a magnetic stir bar was added 5-bromo-2-pentanone (165 mg, 1.00 mmol), trimethyl orthoformate (180 mg, 1.70 mmol) and a glycol (4.00 mmol). The mixture was stirred open to the atmosphere until a clear solution was obtained. To the resulting solution was added 1 drop of 33 % HBr in acetic acid and stirred for the required amount of time under N 2 atmosphere. The reaction was quenched with trimethylamine (0.5 mL). The solution as poured into sat. NaHCO 3 (25 mL) and extracted with hexanes (3 x 20 mL). Combined organic extract was filtered through a plug of silica (0.5 cm x 3 cm). Upon removal of solvent under reduced pressure, the crude extract was purged under high vacuum for 3 h to afford the desired ketal as a clear colourless liquid To a 50 ml two-neck round bottom flask equipped with magnetic stir bar and fitted with a glass stopper and adapter to a Schlenk line was added 26 (6.61 g, 40.0 mmol), trimethyl orthoformate ( 7.5 ml, 73 mmol) and pinacol (12.17 g, 103.0 mmol) under N 2 flow. The vessel was stoppered and mixture was stirred until a clear colourless solution was obtained. To the resulting solution was added HBr (33 % in acetic acid, 0.16 g, 2.0 mmol). The yellow solution was stirred at room temperature for 3 h, then the flask was equipped with a shortpath vacuum distillation apparatus and was stirred at 60 °C overnight. The flask was fitted with a 10 cm Vigreux column topped with a short-path distillation head and the product was isolated under reduced pressure as the highest boiling fraction with the bath temperature set to 80 °C. the title compound was isolated as a clear colourless liquid (8.68 g, 32.7 94, 82.59, 41.39, 34.10, 28.64, 26.94, 24.72, 24.65 .
(3-(2,4,4,5,5-Pentamethyl-1,3-dioxolan-2-yl)propyl)tripropylphosphonium bromide (1e) To a 50 ml two-neck round bottom flask equipped with a magnetic stir bar, condenser connected to N 2 Schlenk line and a septum on the second port, charged with 30 (5.308 g, 20.01 mmol) and NaI (0.134 g, 0.895 mmol), was added THF (20 mL). The septum was replaced with a glass stopper and the suspension was heated at reflux for 5 min under N 2 , allowed to cool to rt. The glass stopper was replaced with septum and tripropylphosphine (4.65 mL, 23.2 mmol) was added to the reaction mixture. The septum was again replaced with a glass stopper and the mixture was heated under reflux for 24 h. The solvent was removed under reduced pressure and CH 2 Cl 2 (25 mL) was added to the viscous residue and the resulting solution was filtered through celite. The solution was concentrated under reduced pressure then the viscous residue was purged of volatiles under vacuum at 65 o C for 2 hours, back filling with N 2 every 0.5 h to afford the title compound as a white solid (8.41 g, 19.8 mmol, 99 % yield) 1 H NMR (600 MHz, CDCl 3 ) δ 2.46-2.42 (m, 8H), 1.79-1.78 (m, 2H), 1.65-1.60 (m, 8H), 1.36 (s, 3H), 1.21 (s, 3H), 1.19 (s, 3H), 1.13 (t, 9H); 13 C NMR (151 MHz, CDCl 3 ) δ 106. 37, 82.81, 43.62, 43.53, 26.88, 24.70, 24.64, 21.46, 21.14, 19.63, 19.32, 17.69, 15.79, 15.76, 15.60, 15.49; 31 P NMR (243 MHz, CDCl 3 ) δ 32.15.
Wittig Procedures
General Procedure A A Microwave reaction tube equipped with a stir bar was charged with the corresponding aldehyde (1 eq.) and the phosphonium salt 1d (1.1 eq.). To the tube, base and H 2 O (1 mL) were added. The tube was sealed and heated at 110 °C overnight. The tube was cooled to room temperature and 5 mL of water was added. The aqueous solution was extracted with EtOAc (2 x 5 mL). The organic layers were combined, dried over anhydrous Na 2 SO 4 and concentrated under vacuum. The crude residue was purified by silica gel column chromatography using EtOAc/hexanes (40:1) to afford the homologated product
General Procedure B To a 25 mL two-neck flask equipped with a with stir bar, charged with phosphonium salt 1d, was added solvent (5 ml) under N 2 . The contents were cooled to 0 °C and base was added via syringe. Upon stirring for 0.5 h, aldehyde was added in a solution of the reaction solvent (2 mL). The mixture was allowed to slowly warm to rt over 10 h.The solvent was exchanged for CH 2 Cl 2 (2 mL). The solution was washed with sat. NH 4 Cl (2 ml), water (2 ml), then dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The crude residue was purified by silica gel column chromatography using EtOAc/hexanes (40:1) to afford the homologated product.
General Procedure C: (Entry 1, 2, 5, 7, 8, 10)
A two neck flask equipped with a magnetic stirring bar, glass stopper, adapter to a two-line Schlenk manifold, charged with salt 1e (85 mg, 0.20 mmol) was purged under vacuum for 0.5 h then filled with N 2 . The glass stopper was quickly exchanged with a rubber septum under rapid N 2 flow and solvent (1.0 ml) was added via syringe then the septum was quickly replaced with a glass stopper. The mixture was stirred until a solution was formed then cooled to 0 o C. To the cooled solution base (0.26 mmol) was quickly added under rapid N 2 flow. Upon stirring for 0.5 h, 4-chlorobenzaldehyde (25 mg, 0.18 mmol) was quickly added and the reaction was allowed to warm to rt overnight. The reaction was quenched with the addition of NH 4 Cl (10 mg), solvent was removed under reduced pressure and the pot residue was extracted with Et 2 O (3 x 1 ml). The combined extract was washed with sat. NH 4 Cl (2 ml), water (2 ml), brine (2 ml), dried with MgSO 4 and solvent was removed under reduced pressure to give a crude extract as a yellow oil that was subject to 1 H NMR analysis.
General Procedure D: (Entry 3, 4)
A two neck flask equipped with a magnetic stirring bar, glass stopper, adapter to a two-line Schlenk manifold, charged with salt 1e (85 mg, 0.20 mmol) was purged under vacuum for 0.5 h then filled with N 2 . The glass stopper was quickly exchanged with a rubber septum under rapid N 2 flow and solvent (1.0 ml) as added via syringe then the septum was quickly replaced with a glass stopper. The mixture was stirred until a solution was formed then cooled to 0 o C. To the cooled solution base (0.26 mmol) was quickly added under rapid N 2 flow. The reaction was allowed to warm to rt over 0.5 h, then 4-chlorobenzaldehyde (25 mg, 0.18 mmol) was quickly added, the septum was replaced and the reaction was stirred overnight. The reaction was quenched with the addition of NH 4 Cl (10 mg), solvent was removed under reduced pressure and the pot residue was extracted with Et 2 O (3 x 1 ml). The combined extract was washed with sat. NH 4 Cl (2 ml), water (2 ml), brine (2 ml), dried with MgSO 4 and solvent was removed under reduced pressure to give a crude extract as a yellow oil that was subject to 1 H NMR analysis.
General Procedure E: (Entry 6)
A two neck flask equipped with a magnetic stirring bar, glass stopper, adapter to a two-line Schlenk manifold, charged with salt 1c (85 mg, 0.20 mmol), 4-chlorobenzaldehyde (25 mg, 0.18 mmol) and was purged under vacuum for 0.5 h then filled with N 2 . The glass stopper was quickly exchanged with a rubber septum under rapid N 2 flow and THF (1.0 ml) as added via syringe then the mixture was cooled to 0 o C. To the cooled solution base (0.26 mmol) was quickly added under rapid N 2 flow. The reaction was allowed to warm to rt overnight. The reaction was quenched with the addition of NH 4 Cl (10 mg), solvent was removed under reduced pressure and the pot residue was extracted with Et 2 O (3 x 1 ml). The combined extract was washed with sat. NH 4 Cl (2 ml), water (2 ml), brine (2 ml), dried with MgSO 4 and solvent was removed under reduced pressure to give a crude extract as a yellow oil that was subject to 1 H NMR analysis.
General Procedure F: (Entry 11)
A two neck flask equipped with a magnetic stirring bar, glass stopper, adapter to a two-line Schlenk manifold, charged with salt 1c (85 mg, 0.20 mmol) was purged under vacuum for 0.5 h then filled with N 2 . The glass stopper was quickly exchanged with a rubber septum under rapid N 2 flow and Et 2 O (0.8 ml) as added via syringe. The mixture was cooled to -78 o C. To the cooled solution n-BuLi (1.6 M in hexanes, 1.3 equiv) was quickly added under rapid N 2 flow. The reaction was allowed to warm to 0 o C over 0.5 h, then 4-chlorobenzaldehyde (25 mg, 0.18 mmol) in Et 2 O (0.2 ml) was transferred to the reaction pot via syringe, the reaction was then allowed to warm to rt, the septum as quickly replaced with a glass stopper and the reaction was stirred overnight. An additional volume of Et 2 O (2 ml) was added and the reaction was quenched with the addition of sat. NH 4 Cl (2 ml). The aqueous was removed and the organic phase was washed with water (2 ml), brine (2 ml), dried with MgSO 4 and solvent was removed under reduced pressure to give a crude extract as a yellow oil that was subject to 1 H NMR analysis.
(E)-2-(3-(4-bromophenyl)allyl)-1,3-dioxolane (9)
Synthesized using the general procedure B. 1.1 eq. of LiHMDS, and 4-bromo-benzaldehyde (100 mg, 0.54 mmol) was used. 
(E)-4-(3-(1,3-dioxolan-2-yl)prop-1-en-1-yl)-N,N-dimethylaniline (12)
Synthesized using the general procedure B. 1.1 eq. of LiHMDS and 4-(Dimethylamino) benzaldehyde (100 mg, 0.67 mmol) was used. 5-(3-(1,3-dioxolan-2-yl)prop-1-en-yl) 13 C NMR (151 MHz, CDCl 3 ) δ 147. 93, 146.89, 132.72, 131.89, 121.96, 120.69, 108.18, 105.59, 103.88, 100.97, 65.05, 37.81 
(E)-

(E)-2-(3-(3,4,5,-trimethoxyphenyl)allyl)-1,3-dioxolane (14)
Synthesized using the general procedure B. 1.1 eq. of LiHMDS and 3,4,5-Trimethoxybenzaldehyde (100 mg, 0.50 mmol) was used. (E)-2-(3-(3,4,5,-trimethoxyphenyl) 47, 135.10, 131.04, 130.18, 127.15, 126.00, 125.51 (d, J = 23.2 Hz), 125.06, 103.97, 65.07, 38.20, 19.84 . HREI MS (M+) cald. for C 13 H 16 O 2 : 204.1150, found 204.1131.
(E)-2-(3-(furan-2-yl)allyl)-1,3-dioxolane (21)
Synthesized using the general procedure B. 1.1 eq. of LiHMDS and furfural (100 mg, 1.04 mmol) was used. (E)-2-(3-(furan-2-yl)allyl)-1,3-dioxolane (140.23 mg, 75%) was obtained as yellow oil.
1 H NMR (600 MHz, CDCl 3 ) δ 7.34 (d, J = 1.5 Hz, 1H), 6.36 (ddd, J = 13.6, 6.7, 3.1 Hz, 2H), 6.19 (dt, J = 15.8, 7.1 Hz, 2H), 5.00 (t, J = 4.7 Hz, 1H), 4.05 -4.01 (m, 2H), 3.92 -3.89 (m, 2H), 2.59 (ddd, J = 7.1, 4.7, 1.3 Hz, 2H).
13 C NMR (151 MHz, CDCl 3 ) δ 153. 09 -152.65, 141.56, 122.64, 121.67, 111.10, 106.90, 103.67, 65.05, 37.67 . HREI MS (M+) cald. for C 10 H 12 O 3 : 180.0780, found 180.0776.
(E)-2-(3-(thiophen-2-yl)allyl)-1,3-dioxolane (19)
Synthesized using the general procedure B. 1.1 eq. of LiHMDS, 2-Thiophenecarboxaldehyde (100 mg, 0.89 mmol) was used. (E)-2-(3-(thiophen-2-yl)allyl)-1,3-dioxolane (132.55 mg, 76%) was obtained as yellow oil.
1 H NMR (600 MHz, CDCl 3 ) δ 7.13 (d, J = 5.0 Hz, 1H), 6.96 (dd, J = 5.0, 3.5 Hz, 1H), 6.93 (d, J = 3.3 Hz, 1H), 6.66 (d, J = 15.7 Hz, 1H), 6.09 (dt, J = 15.6, 7.2 Hz, 1H), 5.00 (t, J = 4.6 Hz, 1H), 4.04 -4.01 (m, 2H), 3.92 -3.89 (m, 2H), 2.58 (ddd, J = 7.1, 4.6, 1.4 Hz, 2H).
13 C NMR (151 MHz, CDCl 3 ) δ 142. 50, 127.20, 126.36, 124.96, 123.66, 123.56, 103.66, 65.07, 37.77 . HREI MS (M+) cald. for C 10 H 12 O 2 S: 196.0558, found 196.0556. 3-(3-(1,3-dioxolan-2-yl)prop-1-en-1-yl) pyridine (18) Synthesized using the general procedure B. 1.1 eq of LiHMDS, 3-Pyridinecarboxaldehyde (100 mg, 0.93 mmol) was used. (E)-3-(3-(1,3-dioxolan-2-yl) prop-1-en-1-yl)pyridine (134.58 mg, 75%) was obtained as yellow oil. 89, 147.74, 133.08, 132.99, 129.51, 126.62, 123.51, 103.46, 65.10, 37.92 119.64, 118.02, 111.57, 103.58, 65.10, 39.24 
(E)-
2-((2E,4E)-4-bromo-5-phenylpenta-2,4-dien-1-yl)-1,3-dioxolane (20)
Synthesized using the general procedure B. 1.1 eq of LiHMDS, α-Bromocinnamaldehyde (100 mg, 0.47 mmol) was used. 2-((2E,4E)-4-bromo-5-phenylpenta-2,4-dien-1-yl)-1,3-dioxolane (85.28 mg, 61%, E:Z = 25:25) was obtained as yellow oil.
1 H NMR (600 MHz, CDCl 3 ) Major isomer: δ 7. 2H), 3H), 1H), 6.07 (dt, J = 10.8, 7.3 Hz, 1H), 1H) , 5.04 (t, J = 4.8 Hz, 1H), 4.07 -4.01 (m, 2H), 3.91 (ddd, J = 4.5, 4.1, 2.3 Hz, 2H), 2.84 (ddd, J = 7.2, 4.8, 1.5 Hz, 2H). 13 C NMR (151 MHz, CDCl 3 ) δ 137. 64, 136.60, 133.60, 131.49, 129.47, 128.29, 128.18, 128.03, 123.40, 113.08, 112.05, 103.27, 65.04, 35.26 . 13 C NMR (151 MHz, CDCl 3 ) δ 140. 29, 120.75, 104.39, 64.94, 40.69, 37.67, 32.96, 26.21, 26 .08.
Scheme 5, Entry 10
General procedure C was followed using salt 1e (427 mg, 1.0 mmol), 4-chlorobenzaldehyde (127 mg, 0.90 mmol) and 1.3 eq of LiHMDS in THF/DMF (1:1). The crude material was purified by flash chromatography (20:1 hexanes/EtOAc) to give separated 31 and 32 as a pale yellow oils containing a mixture of isomers and ~10 % impurities by integral count. A second purification (40:1 hexanes/EtOAc) gave 31 as a pale yellow oil, with depleted (Z)-isomer (6.9 mg, 0. 31, 132.33, 131.47, 128.57, 128.38, 127.10, 107.22, 82.59, 42.46, 29.70, 28.65, 26.95, 24.80, 24.73. Compound 32 was isolated as a pale yellow oil (10.7 mg, 0.064 mmol) 1 H NMR (600 MHz, CDCl 3 ) δ 7.15 (m, 4H), 6.22 (dt, 1H, J = 15.8 Hz), 6.14 (dt, 1H, J = 15.8 Hz), 2.13-2.10 (m, 2H), 0.99 (s, 3H); 13 C NMR (151 MHz, CDCl 3 ) δ 136. 46, 133.37, 128.59, 127.66, 127.12, 29.74, 26.04, 13 .54.
Deprotection and Oxidation
Deprotection of the dioxolane (9)
The compound 9 (0.18 mmol, 50 mg) was dissolved in CH 2 Cl 2 (1 ml). to the solution as added TFA (0.02 ml) and then was stirred at rt for 24 h. TLC indicated the disappearance of the dioxolane compound (9). The solvent was removed under vacuum and the crude was dissolved in EtOAc and washed with sat. NaHCO 3 solution. The organic layer was dried over anhydrous Na 2 SO 4 and purified through silica gel column using 4:1 EtOAc/Hexane. The concentration of the fractions gave a 24 as pale yellow liquid in 90 % yield To a solution of alkene (11) (900 mg, 4.73 mmol) (prepared according to the general procedure C) in aq. t-BuOH (1:1 v/v, 60 mL) at 0 °C was added AD-mix-β (10.15 g, 1.5 eq). To the mixture, added methyl sulfonamide (450 mg, 1 eq.) and stirred for 24 h at room temperature. The reaction was monitored using TLC and after completion, the mixture was treated with sat. Na 2 S 2 O 3 and extracted with EtOAc, and the organic layer was washed with brine. The extract was dried over Na 2 SO 4 and concentrated in vacuum. The residue was purified by silica gel column chromatography (EtOAc/Hexane, 1:1) to give the diol 12 (957 mg, 90%) as a colorless solid. 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220 f1 ( 
